[PDF] Top 20 J. Bras. Nefrol. vol.34 número3 en v34n3a02
Has 10000 "J. Bras. Nefrol. vol.34 número3 en v34n3a02" found on our website. Below are the top 20 most common "J. Bras. Nefrol. vol.34 número3 en v34n3a02".
J. Bras. Nefrol. vol.34 número3 en v34n3a02
... Induction immunosuppressive therapy was used in 49 patients (23%), of which 34 (69%) were treated with basiliximab and 15 (31%) with ATG. However, no significant link to death and infectious diseases, CVD, or ... See full document
10
J. Bras. Nefrol. vol.34 número1 en a14v34n1
... Because of the index case and the parents` consangui- nity, we raised the possibility of BS in the girl`s older and only sister. This second girl had also been pre- maturely born, after a polyhydramnios-complicated ... See full document
5
J. Bras. Nefrol. vol.34 número1 en a04v34n1
... Therefore, the purpose of this study was to com- pare Kt/V results obtained with Lowrie`s formula (L Kt/V) with those obtained with Daugirdas`s for- mula (D Kt/V), and the latter [r] ... See full document
5
J. Bras. Nefrol. vol.34 número1 en a05v34n1
... Introdução: A albumina pré-diálise pode ter sua utilidade questionada na avaliação do estado proteico devido ao efeito dilu- cional nesse período. Objetivos: Avaliar se a albumina sérica dosada no período pós-diálise ... See full document
9
J. bras. pneumol. vol.34 número3 en v34n3a02
... By combining tissue microarray technology and immunohistochemical staining, we identified occult micrometastatic tumor cells in pN0 lymph nodes in 50% of the patients with [r] ... See full document
7
J. Bras. Nefrol. vol.34 número1 en a07v34n1
... Introduction: One of the biggest chal- lenges in the management of hyperten- sion is adequate blood pressure (BP) control. To achieve this goal, home blood pressure measurement (HBPM) with automated devices has been ... See full document
7
J. Bras. Nefrol. vol.34 número1 en a09v34n1
... Therapy with ergocalciferol or colecalciferol in pa- tients with CKD with 25(OH)D deficiency has been little described in literature, thus showing it is associ- ated with high serum lev[r] ... See full document
6
J. Bras. Nefrol. vol.34 número1 en a11v34n1
... This study aimed to assess the impact of demo- graphic, clinical and laboratory variables that were present at admission and let to the outcomes death or renal re[r] ... See full document
8
J. Bras. Nefrol. vol.34 número1 en a01v34n1
... These include de- monstrably successful models of kidney transplant programs in many developing countries; growing availability of less expensive generic immunosuppres- siv[r] ... See full document
7
J. Bras. Nefrol. vol.34 número1 en a16v34n1
... 16. Lang RM, Bierig M, Devereux RB, flachskampf fA, foster e, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of echocardiography’s Guidelines and Standards Committee ... See full document
6
J. Bras. Nefrol. vol.34 número2
... Our study has several limitations. First and fore- most, it was not placebo-controlled. Other studies in the field indicate minimal effects from placebo, so we believed it was not necessary to have a placebo group in our ... See full document
5
J. Bras. Nefrol. vol.34 número2
... lação hepática, são convertidas em 25-vit D. A 25-vit D representa o estoque corporal de vi- tamina D e não deve ser confundida com calcitriol (1,25-vit D) que é um hormônio sintetizado princi- palmente nos rins. ... See full document
7
J. Bras. Nefrol. vol.34 número1
... contribute to it. Therefore, angiotensin converting en- zyme inhibitor and thiazides could be useful to these patients. Our aim is to report the effects of enalapril and hydrochlorothiazide (HCTZ) in two novel ... See full document
4
J. Bras. Nefrol. vol.32 número3 en v32n3a01
... Important lessons were learned during this mission and can be used for the improvement of future interventions, which must consider: planning, team formation, resource/equipment sizing[r] ... See full document
2
J. Bras. Nefrol. vol.32 número3 en v32n3a03
... The parameters assessed in the study were as follo- ws: age (years); sex (male or female); color/race (whi- te or non-white); site of the primary purulent infection (upper airway or ski[r] ... See full document
4
J. Bras. Nefrol. vol.34 número1 en a02v34n1
... Methods: Symptomatic patients, patients with ischemia on myocar- dial scintigraphy and/or systolic dysfunc- tion on echocardiography, patients older than 50 years and diabetes[r] ... See full document
8
J. Bras. Nefrol. vol.34 número4 en v34n4a11
... 1. Kosmadakis GC, Bevington A, Smith AC, Clapp EL, Viana JL, Bishop NC, et al. Physical exercise in patients with se- vere kidney disease. Nephron Clin Pract 2010;115:c7-c16. 2. Jatobá JPC, Amaro WF, Andrade APA, ... See full document
9
J. Bras. Nefrol. vol.34 número3
... 6. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Compa- rison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease ... See full document
3
J. Bras. Nefrol. vol.34 número3 en v34n3a04
... 2,3 Patients undergoing hemodialysis show a higher death rate due to cardiac arrhythmia when compared to patients undergoing peritoneal dialysis [62 versus 42 events/(1000 patients/ye[r] ... See full document
8
J. Bras. Nefrol. vol.34 número3 en v34n3a05
... Based on these data, the objectives of the present research were as follows: (1) identify and characterize, clinically and epidemiologically, hypertensive patients who had renal arter[r] ... See full document
8
temas relacionados